Today: 9 June 2026
KOSPI’s next test: exports jump ahead of Korea Exchange’s Jan. 2 reopen
1 January 2026
1 min read

KOSPI’s next test: exports jump ahead of Korea Exchange’s Jan. 2 reopen

NEW YORK, January 1, 2026, 09:06 ET — Market closed

Investors headed into South Korea’s first trading session of 2026 with a strong export print in hand. Exports rose 13.4% in December from a year earlier, beating forecasts, and 2025 shipments climbed to a record $709.7 billion, government data showed on Thursday.

The benchmark KOSPI last finished 0.15% lower at 4,214.17 on Dec. 30, the final trading day of 2025 on the Korea Exchange (KRX). The tech-heavy Kosdaq ended down 0.76% at 925.47, local market data showed.

That setup matters because South Korea is starting the new year with equities sitting near record highs after a chip-led rally, while investors reassess how much of the good news is already in the price. Fresh trade and inflation data can quickly swing expectations for the won and interest rates — and foreign fund flows tend to follow.

Chip heavyweights outperformed even as regional trading stayed subdued into the holidays. SK Hynix rose 1.72% and Samsung Electronics added 0.33% in the last session, while battery names lagged, with LG Energy Solution down 3% and Samsung SDI off 2.9%, market data showed.

Korean shares still closed out 2025 up 75.6% — the biggest yearly rise since 1999 — helped by the global artificial intelligence boom that lifted semiconductor stocks and by government market reform efforts, Reuters reported. The Seoul market was closed on Dec. 31 and Jan. 1 for year-end holidays.

“We expect the KOSPI, still undervalued, to be on its own upward trend next year,” Daishin Securities analyst Lee Kyoung-min said. He set a 2026 target of 5,300, pointing to a semiconductor up-cycle — a period when chip demand and pricing improve — and a policy push aimed at shrinking the “Korea discount,” shorthand for Korean equities’ valuation gap tied to governance and dividend practices; the record high is 4,226.75, set on Nov. 4. Business Recorder

On the macro side, inflation data may shape the rate narrative just as trading restarts. South Korea’s consumer inflation slowed to 2.1% in 2025, close to the Bank of Korea’s 2% target, and December CPI rose 2.3% year-on-year in line with forecasts, Reuters reported.

Before next session

Korea Exchange will start regular trading at 10 a.m. local time on Jan. 2, one hour later than usual, after a market-opening ceremony; it will still close at the normal 3:30 p.m., Seoul Economic Daily reported. Alternative trading platform NextTrade will not run its pre-market session that morning.

Investors also have a clear policy waypoint: the Bank of Korea’s first rate-setting meeting of 2026 is scheduled for Thursday, Jan. 15, according to the central bank’s published calendar.

Stock Market Today

  • United Natural Foods Shares Fall 12% After Q3 Revenue Miss, Profit Meets Estimates
    June 9, 2026, 1:24 PM EDT. United Natural Foods (UNFI) shares dropped 12.4% following a fiscal Q3 revenue miss. The company reported sales of $7.72 billion, below the $7.80 billion analyst consensus, despite meeting adjusted earnings per share (EPS) forecasts at 77 cents. Net sales fell 4.2% year-over-year, driven by a 13.6% decline in conventional sales, while natural-product sales rose 4.4%. UNFI posted a net income of $33 million after a prior-year loss, with adjusted EBITDA up 16.6% to $183 million. Management outlined plans for network optimization and cost reductions amid risks from fuel costs and consumer pressure. The full-year sales outlook of $31.1-31.3 billion was slightly below consensus but confirmed adjusted EPS guidance of $2.40-$2.60.

Latest articles

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

9 June 2026
Archer Aviation plunged 9.1% to $5.21 after ARK Invest dumped over 2.2 million shares worth $12.7 million, intensifying pressure as investors fled speculative growth stocks; with FAA certification still pending and heavy cash burn, Archer’s stock remains vulnerable to further selloffs if milestones slip.
Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

9 June 2026
Aurora shares dropped 3.5% to $6.04 as tech and autonomous-driving stocks slid, with Uber’s recent block sale of 67.5 million shares at $7.10 still weighing on sentiment; Aurora reported a Q1 net loss of $223 million on $1 million revenue, expects continued losses, and may need to raise more capital to support its commercial ramp.
United Natural Foods Shares Fall After Revenue Miss

United Natural Foods Shares Fall After Revenue Miss

9 June 2026
United Natural Foods plunged 12.4% to $45.25 after quarterly revenue missed estimates, falling 4.2% to $7.72 billion versus the $7.80 billion consensus, with full-year guidance also slightly below Wall Street expectations, despite matching adjusted EPS and improved profit and debt metrics.
BlackBerry Shares Stall After QNX Push

BlackBerry Shares Slip Ahead of Results — What’s Moving BB Today

9 June 2026
BlackBerry’s U.S. shares plunged 8.5% to $8.50 as investors braced for the June 25 earnings report, with focus on whether the company can meet its bullish Q1 revenue forecast of $132–$140 million, well above analysts’ estimates, after QNX’s 20% revenue jump and $950 million royalty backlog last quarter.
Chip Selloff Trips Up Wall Street’s AI Rally

Chip Selloff Trips Up Wall Street’s AI Rally

9 June 2026
Nasdaq and S&P 500 tumbled midday, erasing early chip-stock gains as tech shares slid; Philadelphia Semiconductor Index dropped 2% after jumping 3%, with Broadcom, Micron, and Nvidia under pressure. Investors await key inflation data Wednesday and SpaceX’s massive IPO, both seen as catalysts for further volatility amid concerns that high valuations in AI and tech could face profit-taking if rate fears persist.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop